No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes

MLA

Sean P. Lyden, et al. “No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.” Journal of Endovascular Therapy, vol. 29, Jan. 2022, pp. 929–36. EBSCOhost, https://doi.org/10.1177/15266028211068769.

APA

Sean P. Lyden, Peter L. Faries, Khusrow A. K. Niazi, Ravish Sachar, Ash Jain, Marianne Brodmann, Martin Werner, Ami Sood, & Prakash Krishnan. (2022). No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes. Journal of Endovascular Therapy, 29, 929–936. https://doi.org/10.1177/15266028211068769

Chicago

Sean P. Lyden, Peter L. Faries, Khusrow A. K. Niazi, Ravish Sachar, Ash Jain, Marianne Brodmann, Martin Werner, Ami Sood, and Prakash Krishnan. 2022. “No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.” Journal of Endovascular Therapy 29 (January): 929–36. doi:10.1177/15266028211068769.